vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and BWX Technologies, Inc. (BWXT). Click either name above to swap in a different company.
BWX Technologies, Inc. is the larger business by last-quarter revenue ($885.8M vs $821.5M, roughly 1.1× Acadia Healthcare Company, Inc.). BWX Technologies, Inc. runs the higher net margin — 10.5% vs -143.3%, a 153.8% gap on every dollar of revenue. On growth, BWX Technologies, Inc. posted the faster year-over-year revenue change (18.7% vs 6.1%). BWX Technologies, Inc. produced more free cash flow last quarter ($56.8M vs $-179.5M). Over the past eight quarters, BWX Technologies, Inc.'s revenue compounded faster (21.1% CAGR vs 3.4%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
BWX Technologies, Inc. is a company headquartered in Lynchburg, Virginia that supplies nuclear components and fuel internationally.
ACHC vs BWXT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $821.5M | $885.8M |
| Net Profit | $-1.2B | $93.0M |
| Gross Margin | — | — |
| Operating Margin | -142.4% | 10.4% |
| Net Margin | -143.3% | 10.5% |
| Revenue YoY | 6.1% | 18.7% |
| Net Profit YoY | -3710.4% | 30.9% |
| EPS (diluted) | $-12.98 | $1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $821.5M | $885.8M | ||
| Q3 25 | $851.6M | $866.3M | ||
| Q2 25 | $869.2M | $764.0M | ||
| Q1 25 | $770.5M | $682.3M | ||
| Q4 24 | $774.2M | $746.3M | ||
| Q3 24 | $815.6M | $672.0M | ||
| Q2 24 | $796.0M | $681.5M | ||
| Q1 24 | $768.1M | $604.0M |
| Q4 25 | $-1.2B | $93.0M | ||
| Q3 25 | $36.2M | $82.1M | ||
| Q2 25 | $30.1M | $78.4M | ||
| Q1 25 | $8.4M | $75.5M | ||
| Q4 24 | $32.6M | $71.0M | ||
| Q3 24 | $68.1M | $69.5M | ||
| Q2 24 | $78.5M | $73.0M | ||
| Q1 24 | $76.4M | $68.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 21.8% | ||
| Q2 25 | — | 25.1% | ||
| Q1 25 | — | 24.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.4% | ||
| Q2 24 | — | 24.7% | ||
| Q1 24 | — | 24.6% |
| Q4 25 | -142.4% | 10.4% | ||
| Q3 25 | 4.7% | 13.1% | ||
| Q2 25 | 5.8% | 13.4% | ||
| Q1 25 | 1.7% | 14.2% | ||
| Q4 24 | 4.9% | 12.4% | ||
| Q3 24 | 12.1% | 14.4% | ||
| Q2 24 | 13.4% | 14.5% | ||
| Q1 24 | 12.9% | 15.4% |
| Q4 25 | -143.3% | 10.5% | ||
| Q3 25 | 4.3% | 9.5% | ||
| Q2 25 | 3.5% | 10.3% | ||
| Q1 25 | 1.1% | 11.1% | ||
| Q4 24 | 4.2% | 9.5% | ||
| Q3 24 | 8.4% | 10.3% | ||
| Q2 24 | 9.9% | 10.7% | ||
| Q1 24 | 9.9% | 11.3% |
| Q4 25 | $-12.98 | $1.02 | ||
| Q3 25 | $0.40 | $0.89 | ||
| Q2 25 | $0.33 | $0.85 | ||
| Q1 25 | $0.09 | $0.82 | ||
| Q4 24 | $0.36 | $0.77 | ||
| Q3 24 | $0.74 | $0.76 | ||
| Q2 24 | $0.85 | $0.79 | ||
| Q1 24 | $0.83 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.2M | $499.8M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $1.9B | $1.2B |
| Total Assets | $5.5B | $4.3B |
| Debt / EquityLower = less leverage | 1.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.2M | $499.8M | ||
| Q3 25 | $118.7M | $79.6M | ||
| Q2 25 | $131.4M | $37.0M | ||
| Q1 25 | $91.2M | $55.4M | ||
| Q4 24 | $76.3M | $74.1M | ||
| Q3 24 | $82.1M | $35.5M | ||
| Q2 24 | $77.2M | $48.3M | ||
| Q1 24 | $77.3M | $45.9M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
| Q4 25 | $1.9B | $1.2B | ||
| Q3 25 | $3.1B | $1.2B | ||
| Q2 25 | $3.1B | $1.2B | ||
| Q1 25 | $3.0B | $1.1B | ||
| Q4 24 | $3.1B | $1.1B | ||
| Q3 24 | $3.0B | $1.1B | ||
| Q2 24 | $3.0B | $998.5M | ||
| Q1 24 | $2.9B | $946.2M |
| Q4 25 | $5.5B | $4.3B | ||
| Q3 25 | $6.4B | $3.8B | ||
| Q2 25 | $6.3B | $3.7B | ||
| Q1 25 | $6.1B | $3.1B | ||
| Q4 24 | $6.0B | $2.9B | ||
| Q3 24 | $5.9B | $2.9B | ||
| Q2 24 | $5.7B | $2.8B | ||
| Q1 24 | $5.5B | $2.8B |
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-86.3M | $127.0M |
| Free Cash FlowOCF − Capex | $-179.5M | $56.8M |
| FCF MarginFCF / Revenue | -21.8% | 6.4% |
| Capex IntensityCapex / Revenue | 11.3% | 7.9% |
| Cash ConversionOCF / Net Profit | — | 1.37× |
| TTM Free Cash FlowTrailing 4 quarters | $-439.9M | $295.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-86.3M | $127.0M | ||
| Q3 25 | $73.2M | $143.2M | ||
| Q2 25 | $133.5M | $159.0M | ||
| Q1 25 | $11.5M | $50.6M | ||
| Q4 24 | $116.7M | $276.9M | ||
| Q3 24 | $163.1M | $32.6M | ||
| Q2 24 | $171.1M | $65.9M | ||
| Q1 24 | $-321.3M | $33.0M |
| Q4 25 | $-179.5M | $56.8M | ||
| Q3 25 | $-63.0M | $94.9M | ||
| Q2 25 | $-34.2M | $126.3M | ||
| Q1 25 | $-163.2M | $17.3M | ||
| Q4 24 | $-86.8M | $224.4M | ||
| Q3 24 | $-27.1M | $-7.7M | ||
| Q2 24 | $16.9M | $35.5M | ||
| Q1 24 | $-463.7M | $2.6M |
| Q4 25 | -21.8% | 6.4% | ||
| Q3 25 | -7.4% | 11.0% | ||
| Q2 25 | -3.9% | 16.5% | ||
| Q1 25 | -21.2% | 2.5% | ||
| Q4 24 | -11.2% | 30.1% | ||
| Q3 24 | -3.3% | -1.1% | ||
| Q2 24 | 2.1% | 5.2% | ||
| Q1 24 | -60.4% | 0.4% |
| Q4 25 | 11.3% | 7.9% | ||
| Q3 25 | 16.0% | 5.6% | ||
| Q2 25 | 19.3% | 4.3% | ||
| Q1 25 | 22.7% | 4.9% | ||
| Q4 24 | 26.3% | 7.0% | ||
| Q3 24 | 23.3% | 6.0% | ||
| Q2 24 | 19.4% | 4.5% | ||
| Q1 24 | 18.5% | 5.0% |
| Q4 25 | — | 1.37× | ||
| Q3 25 | 2.02× | 1.74× | ||
| Q2 25 | 4.43× | 2.03× | ||
| Q1 25 | 1.37× | 0.67× | ||
| Q4 24 | 3.58× | 3.90× | ||
| Q3 24 | 2.39× | 0.47× | ||
| Q2 24 | 2.18× | 0.90× | ||
| Q1 24 | -4.21× | 0.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
BWXT
| Nuclear Component Program | $436.4M | 49% |
| Nuclear Manufacturing | $134.8M | 15% |
| Cost Plus Fee | $116.1M | 13% |
| Uranium And Nuclear Services | $103.8M | 12% |
| Commercial Operations | $49.0M | 6% |
| Commercial Operations Segment | $33.7M | 4% |
| Transferred At Point In Time | $1.3M | 0% |
